Oncology & Cancer

Faulty gene connected to ovarian cancer risk

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expected ...

Vaccination

Vaccine-poor Germans shunning AstraZeneca jab

Doctors and public health officials pleaded with Germans Thursday to take up AstraZeneca vaccines against the coronavirus after muddled communication about the efficacy of the British-made jabs hit demand.

Diseases, Conditions, Syndromes

AstraZeneca vaccine effective in over-80s: study

The AstraZeneca/Oxford COVID-19 vaccine appears to be more than 80 percent effective at preventing severe illness among elderly, at-risk individuals after a single dose, according to preliminary research published Wednesday.

page 3 from 34